RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Gritstone bio - Stock

Gritstone bio EBIT 2024

Gritstone bio EBIT

-143.45 M USD

Ticker

GRTS

ISIN

US39868T1051

WKN

A2N4RX

In 2024, Gritstone bio's EBIT was -143.45 M USD, a 2.74% increase from the -139.62 M USD EBIT recorded in the previous year.

The Gritstone bio EBIT history

YEAREBIT (undefined USD)
2029e-
2028e-
2027e-
2026e-
2025e-
2024e-
2023-
2022-
2021-
2020-
2019-
2018-
2017-
2016-

Gritstone bio Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Gritstone bio, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Gritstone bio from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Gritstone bio’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Gritstone bio. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Gritstone bio’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Gritstone bio’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Gritstone bio’s growth potential.

Gritstone bio Revenue, EBIT and net profit per share

DateGritstone bio RevenueGritstone bio EBITGritstone bio Net Income
2029e519.42 M undefined0 undefined107.42 M undefined
2028e185.48 M undefined-145 M undefined19.93 M undefined
2027e59.96 M undefined-211.12 M undefined-46.51 M undefined
2026e12.23 M undefined-189.31 M undefined-132.89 M undefined
2025e12.66 M undefined-152.47 M undefined-109.39 M undefined
2024e15.84 M undefined-143.45 M undefined-119.3 M undefined
202316.34 M undefined-139.62 M undefined-138.49 M undefined
202219.95 M undefined-120.43 M undefined-119.69 M undefined
202148.21 M undefined-75.21 M undefined-75.08 M undefined
20204.04 M undefined-106.02 M undefined-105.31 M undefined
20194.37 M undefined-97.94 M undefined-94.43 M undefined
20181.19 M undefined-65.58 M undefined-64.78 M undefined
20170 undefined-41.76 M undefined-41.38 M undefined
20160 undefined-18.98 M undefined-18.75 M undefined

Gritstone bio stock margins

The Gritstone bio margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Gritstone bio. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Gritstone bio.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Gritstone bio's sales revenue. A higher gross margin percentage indicates that the Gritstone bio retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Gritstone bio's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Gritstone bio's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Gritstone bio's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Gritstone bio. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Gritstone bio's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Gritstone bio Margin History

Gritstone bio Gross marginGritstone bio Profit marginGritstone bio EBIT marginGritstone bio Profit margin
2029e0 %0 %20.68 %
2028e0 %-78.17 %10.75 %
2027e0 %-352.09 %-77.57 %
2026e0 %-1,548.28 %-1,086.85 %
2025e0 %-1,204.27 %-863.99 %
2024e0 %-905.55 %-753.11 %
20230 %-854.26 %-847.34 %
20220 %-603.66 %-599.95 %
20210 %-156 %-155.74 %
20200 %-2,624.26 %-2,606.68 %
20190 %-2,241.19 %-2,160.87 %
20180 %-5,510.92 %-5,443.7 %
20170 %0 %0 %
20160 %0 %0 %

Gritstone bio Aktienanalyse

What does Gritstone bio do?

Gritstone Oncology Inc. is a biotechnology company based in California, USA, that develops innovative cancer immunotherapies. It was founded in 2015 by Dr. Andrew Allen and Dr. Alex Chaudhuri, and has been listed on the Nasdaq stock exchange with the ticker "GRTS" since 2018. The founders previously worked in the field of immunotherapy at Roche and Takeda and recognized the potential of personalized cancer therapies using immunology and cancer genomics technologies. With funding of over $220 million from investors such as Versant Ventures, The Column Group, and Frazier Healthcare Partners, the company has experienced strong growth in recent years. Gritstone Oncology follows an integrated business model that includes innovative platform technologies for identifying tumor antigens and developing personalized immunotherapies. The company uses advanced sequencing technologies and data analysis methods to detect individual cancer mutations and develop tailored therapies. Gritstone Oncology has two main product categories: cancer immunotherapies and cancer diagnostics. The company is developing various immunotherapies for the treatment of cancer, including a novel SARS-CoV-2/COVID-19 vaccine based on the same platform as their cancer immunotherapies. Additionally, Gritstone Oncology has developed a proprietary platform for the development of bispecific antibodies, which can simultaneously target two different objectives. They are also developing personalized immunotherapies that specifically target an individual patient's cancer mutations. The company also offers diagnostic tests to identify cancer mutations and determine therapeutic options. These include GPS Cancer, a genomic test that enables personalized cancer diagnosis and therapy, and SLATE, a diagnostic test that analyzes the immune status of tumor cells and surrounding tissues to develop personalized immunotherapy. In conclusion, Gritstone Oncology has become a leading company in the field of personalized cancer immunotherapy. It has strong growth potential due to its innovative technologies and research, as well as its highly experienced leadership and employees. The company will continue to play a critical role in cancer research and therapy and has the potential to improve the lives of millions of people worldwide. Gritstone bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Gritstone bio's EBIT

Gritstone bio's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Gritstone bio's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Gritstone bio's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Gritstone bio’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Gritstone bio Stock

How much did Gritstone bio achieve in EBIT for the current year?

In the current year, Gritstone bio has achieved an EBIT of -143.45 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Gritstone bio.

How has the EBIT of Gritstone bio developed in recent years?

The EBIT of Gritstone bio has increased by 2.741% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Gritstone bio?

The EBIT of Gritstone bio is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Gritstone bio pay?

Over the past 12 months, Gritstone bio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Gritstone bio is expected to pay a dividend of 0 USD.

What is the dividend yield of Gritstone bio?

The current dividend yield of Gritstone bio is .

When does Gritstone bio pay dividends?

Gritstone bio pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Gritstone bio?

Gritstone bio paid dividends every year for the past 0 years.

What is the dividend of Gritstone bio?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Gritstone bio located?

Gritstone bio is assigned to the 'Health' sector.

Wann musste ich die Aktien von Gritstone bio kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Gritstone bio from 7/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/4/2024.

When did Gritstone bio pay the last dividend?

The last dividend was paid out on 7/4/2024.

What was the dividend of Gritstone bio in the year 2023?

In the year 2023, Gritstone bio distributed 0 USD as dividends.

In which currency does Gritstone bio pay out the dividend?

The dividends of Gritstone bio are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Gritstone bio

Our stock analysis for Gritstone bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Gritstone bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.